Adjunctive therapy with an oral H2S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fraction is a research paper published in British Journal of Pharmacology (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
American Heart Association
Grant: 20POST35200075
National Institutes of Health
Grant: AA029984
National Institutes of Health
Grant: HL146098
National Institutes of Health
Grant: HL146514
National Institutes of Health
Grant: HL151398
National Institutes of Health
Grant: HL159428
National Institutes of Health
Grant: P20GM135002
National Institutes of Health
Grant: TL1TR003106
National Institutes of Health
Grant: U54GM104940
NIGMS NIH HHS
Grant: P20 GM103538
NHLBI NIH HHS
Grant: R01 HL151398
NHLBI NIH HHS
Grant: R01 HL146098
NHLBI NIH HHS
Grant: R01 HL146514
NHLBI NIH HHS
Grant: R01 HL159428
NIDDK NIH HHS
Grant: P30 DK072476
NIAAA NIH HHS
Grant: R01 AA029984
MeSH Terms
Keywords